SCHEMBL8204367

SCHEMBL8204367

Clc1cccc2c1Oc1ccccc1N=C2N1CCN(Cc2ccc3c(c2)OCO3)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 4/20 0.55
DRD2 P14416 3/20 0.55
ALDH1A1 P00352 5/20 0.54
HRH4 Q9H3N8 1/20 0.52
TSHR P16473 2/20 0.51
LMNA P02545 2/20 0.51
HTR1A P08908 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
USP2 O75604 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 1/20 0.50
CYP2D6 P10635 1/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50
NFKB1 P19838 1/20 0.50
SLC6A2 P23975 1/20 0.50
MAPK1 P28482 1/20 0.50
SLC6A4 P31645 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204046 0.86 ALDH1A1 (0.52) DRD1DRD2ALDH1A1TSHRLMNA
SCHEMBL8207384 0.85 L3MBTL1 (0.57) DRD1DRD2ALDH1A1LMNAHTR1A
SCHEMBL8994839 0.83 DRD2 (0.67) DRD1DRD2ALDH1A1HRH4HTR1A
SCHEMBL8202569 0.83 DRD1 (0.64) DRD1DRD2ALDH1A1TSHRLMNA
SCHEMBL9050765 0.81 ALDH1A1 (0.57) DRD1DRD2ALDH1A1TSHRHTR1A
SCHEMBL9050759 0.79 DRD2 (0.62) DRD1DRD2ALDH1A1TSHRLMNA
SCHEMBL8203933 0.79 DRD2 (0.74) DRD1DRD2ALDH1A1HRH4TSHR
SCHEMBL8203911 0.79 DRD2 (0.75) DRD1DRD2ALDH1A1HRH4LMNA
SCHEMBL8204496 0.77 DRD2 (0.77) DRD1DRD2ALDH1A1HRH4TSHR
SCHEMBL8204163 0.77 DRD2 (0.64) DRD1DRD2ALDH1A1HRH4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0736024-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1996-10-09 EP claimed
WO-1995017400-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-06-29 WO claimed
US-6103715-A COMPOUNDS THAT BIND TO THE DOPAMINE D4 RECEPTOR AND THEIR USE AS ANXIOLYTIC AGENTS, TREATMENT FOR SCHIZOPHRENIA, AND DRUG SCREENING; SIDE EFFECT REDUCTIOON ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-15 US disclosed
EP-0736024-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1996-10-09 EP disclosed
US-5538965-A TREATMENT OF PSYCHOLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA AND ANXIETY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1996-07-23 US disclosed
WO-1995017400-A1 N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-06-29 WO disclosed